KoBioLabs

KoBioLabs Financing Cash Flow

The Net Financing Cash Flow of KoBioLabs (348150.KQ) as of Nov 16, 2026 is -6.51 B KRW. In the previous year, Net Financing Cash Flow was 4.05 B KRW — a change of -260.97% (lower).

Financing Cash Flow

-6.51 BKRW

YoY

-260.97%

Last updated:

Net Financing Cash Flow of KoBioLabs is 2024 -6.51 B KRW. Net Financing Cash Flow of KoBioLabs was 2023 4.05 B KRW. It decreases by -260.97% lower compared to the previous year.

The KoBioLabs Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2018
44.72 M KRW
Jan 1, 2019
30.60 B KRW
Jan 1, 2020
31.05 B KRW
Jan 1, 2021
55.74 B KRW
Jan 1, 2022
36.31 B KRW
Jan 1, 2023
4.05 B KRW
Jan 1, 2024
-6.51 B KRW
The KoBioLabs Financing Cash Flow history
YEARFinancing Cash FlowYoY
-6.51 BKRW-260.97%
4.05 BKRW-88.86%
36.31 BKRW-34.86%
55.74 BKRW+79.55%
31.05 BKRW+1.44%
30.60 BKRW+68,331.34%
44.72 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

KoBioLabs Stock analysis

What does KoBioLabs do? KoBioLabs Inc., headquartered in Seoul, South Korea, operates in the Health Care sector, specializing in biotechnology. The company focuses on research and development of the microbiome, developing products such as Bioviom and Queens henna FOODOLOGY, as well as new microbiome drugs. It provides commissioned research services and sells its products domestically and internationally. Listed on 18 November 2020, KoBioLabs is active in both domestic and overseas markets. KoBioLabs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KoBioLabs stock

Net Financing Cash Flow of KoBioLabs is -6.51 B KRW in 2024.

Net Financing Cash Flow of KoBioLabs changed from 4.05 B KRW to -6.51 B KRW, representing a -260.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow KoBioLabs since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's KoBioLabs historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — KoBioLabs

All Key Metrics — KoBioLabs